Introduction
The Myroides genus was created in 1996 1 for Flavobacterium odoratum species which were excluded from the Flavobacterium genus by Bernardet et al 2 due to important genomic and phenotypic differences. The new Myroides genus comprises two species, Myroides odoratus (former F. odoratum) and Myroides odoratimimus, which are Gram-negative rods, strictly aerobic, non-motile, with yellow pigmentation and a characteristic fruity odor. 1 Myroides spp. are commonly found in environmental sources, particularly in soil 3, 4 and water, 5, 6 but have also been isolated from seafood products, 7 meat-processing plants, 8 and the gut of adult flesh flies. 9 Members of the Myroides genus also behave as low-grade opportunistic pathogens, causing community- 10 or hospital-acquired [11] [12] [13] infections. Myroides spp. have been found to be responsible for cases of soft tissue infections, 10, 14 septic shock and pneumonia, 14, 15 systemic infections, 11, 12, 16, 17 necrotizing fasciitis, 18 urinary tract infections (UTIs), 19, 20 or erysipelas. 
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Licker et al
We report an outbreak of UTIs caused by M. odoratimimus in a Romanian hospital, which is, to our knowledge, the first outbreak recorded in our country and the third described in the literature to date. 19, 20 
Patients and methods

Study population
During a 3-month period (from June to August 2017), four isolates of Myroides spp. were identified among the 333 positive urine cultures analyzed in the Microbiology Laboratory of the "Pius Brînzeu" Emergency Clinical County Hospital, Timişoara, Romania. This institution is a 1,173-bed, tertiary care, universityaffiliated hospital providing health care services for the western region of Romania. The study was approved by the Hospital Ethics Committee. Patients signed an informed consent upon admission, which included the fact that data recorded during hospitalization could be used for future research studies.
Microbiological analysis and data collection
All isolates were first identified as Myroides spp. using the VITEK ® 2 GN ID cards (BioMérieux, Marcy l'Etoile, France) and then confirmed as M. odoratimimus by the matrix assisted laser desorption/ionization-time of flight mass spectrometry (Bruker Daltonics, Bremen, Germany) system. Antimicrobial susceptibility tests (AST) were performed using the VITEK 2 GN AST-N222 cards by determination of the minimum inhibitory concentration (MIC) and classification into resistance phenotypes. The following antimicrobial agents were tested: ticarcillin, piperacillin, piperacillin/tazobactam, ceftazidime, cefepime, aztreonam, imipenem, meropenem, amikacin, gentamicin, tobramycin, ciprofloxacin, pefloxacin, minocycline, colistin, and trimethoprim-sulfamethoxazole. MIC results were interpreted according to the Clinical and Laboratory Standards Institute criteria. Extensive drug resistance was defined as acquired resistance to at least one agent in all, but two or fewer antimicrobial categories. 21 Hospital records of all patients with positive M. odoratimimus urine cultures were reviewed retrospectively. The collected data included the demographic characteristics of the patients, comorbidities, and the presence of an indwelling urinary catheter. The antimicrobial treatment and the clinical outcomes were individually reviewed.
Results
Four cases of M. odoratimimus-positive urine cultures were identified in the Microbiology Laboratory of the "Pius Brînzeu" Emergency Clinical County Hospital, Timişoara, between June and August 2017. The isolates were recovered from patients admitted to the departments of urology (two cases), surgery (one case), and diabetes (one case), respectively.
Demographics and clinical data of the patients are shown in Table 1 . Three (75%) patients were males and one (25%) was a female. The mean age was 56 years (range 36-72). The patient hospitalized in the surgery department (C1) had a case history of kidney transplantation for chronic glomerulonephritis and was under immunosuppressive treatment. He was also suffering from anal condylomatosis, for which he underwent multiple surgical interventions (the last one 4 days before presentation at the emergency room). He was admitted for abdominal pain and anuria. The female patient (C2) had diabetes mellitus and was hospitalized for diabetic ketoacidosis. One of the patients admitted to the urology department (C3) had a case history of transurethral resection of the prostate for benign prostatic hyperplasia and was suffering from COPD, for which he was on long-term corticosteroid treatment; he was admitted for acute urinary retention. The other patient from the urology department (C4) had undergone a radical cystectomy with bilateral cutaneous ureterostomy for a muscle-invasive bladder cancer 3 months earlier. He was admitted for the replacement of the ureterostomy tubes.
Three cases (C1-C3) underwent urinary catheterization with a Foley's catheter on presentation at the emergency room (one for acute urinary retention and two for accurate monitoring of urinary output). These patients also complained of symptoms characteristic of UTI (fever, flank pain, costovertebral angle tenderness, or pelvic discomfort) and their urinalysis showed the presence of nitrites, leukocyte esterase, and more than five white blood cells per high-power field. All these cases were hospital-acquired UTIs, with a mean duration of hospitalization of 11 days (range 2-23) before isolation of the uropathogen.
AST and the determination of MICs revealed that all M. odoratimimus isolates were sensitive only to minocycline and were resistant to beta-lactams (including extendedspectrum cephalosporins and beta-lactamase inhibitors), monobactams, carbapenems, aminoglycosides, fluoroquinolones, polymyxins, and sulfonamides. One isolate demonstrated intermediate susceptibility to piperacillin/tazobactam. MICs of the antimicrobial agents are shown in Table 2 .
Two patients (C2 and C3) received tigecycline for the treatment of UTIs with a good clinical response. One patient (C1) had been receiving antibiotic treatment for a pelvic 
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Extensively drug-resistant Myroides odoratimimus UTIs abscess (with imipenem, amikacin, colistin) for 22 days at the time the microorganism was isolated in urine, with a favorable outcome.
In accordance with the European Association of Urology guidelines, 22 C4 did not receive antibiotic treatment as no symptoms were present in this patient.
Discussion
Myroides spp. are Gram-negative bacilli frequently encountered in the environment, usually in sources such as water and soil. [3] [4] [5] [6] They are uncommon pathogens in humans, having been reported as causing opportunistic infections, most often in severely immunocompromised hosts. 11, [23] [24] [25] Only rarely have they been identified in immunocompetent patients. 10, 14 The present outbreak of UTIs due to M. odoratimimus is the third described in the literature to date. We reviewed the cases reported in literature to date ( 20 covering a 3-year period showed that patients with F. odoratum UTIs were catheterized and had either neoplasia of the urinary tract or urinary calculi. In the current report, two of the four patients had urological comorbidities (transurethral resection of the prostate for benign prostatic hyperplasia and cystectomy with bilateral cutaneous ureterostomy for bladder cancer). The four M. odoratimimus cases reported in this study were urinary sources only, although it appears this pathogen may be potentially isolated in other sites. A recently published Indian case report discussed isolating M. odoratimimus from both urine and blood cultures of a patient with anaplastic astrocytoma. 28 All our patients with M. odoratimimus UTIs had an indwelling urinary device and all except one (C4) have been hospitalized for lengthy periods. The most important predisposing factor for hospital-acquired UTIs is urinary catheterization, which reduces host defense mechanisms and offers easier access of germs to the bladder. 29 It is possible that C4 acquired the uropathogen prior to admission, most probably 3 months earlier during his previous hospitalization for radical cystectomy, when he had ureterostomy tubes placed.
We suspect that the current outbreak arose in the emergency room where patients underwent urinary catheterization, In the current outbreak, all the patients who developed M. odoratimimus UTIs were immunocompromised. Diabetes mellitus, chronic corticosteroid treatment for COPD, and liver cirrhosis have all been previously identified as causes of immunodepression in patients with Myroides spp. infections. 11, [23] [24] [25] Myroides spp. are known to be resistant to a wide range of antimicrobial agents, including beta-lactams, monobactams, carbapenems, and aminoglycosides. 27 The resistance to betalactams is due to the production of chromosome-encoded metallo-beta-lactamases, TUS-1 for M. odoratus and MUS-1 for M. odoratimimus. 13 Due to their multiple antibiotic resistance mechanisms, 31 a fast and reliable identification method for Myroides spp. is needed. Schrottner et al showed that the VITEK 2 diagnostic system is suitable for identifying bacteria at the genus level, but cannot differentiate between species. In contrast to this, matrix assisted laser desorption/ ionization-time of flight mass spectrometry and 16S rDNA are methods capable of distinguishing between M. odoratus and M. odoratimimus. 32 Choosing the appropriate antimicrobial treatment for Myroides infections can be quite challenging because of the limited clinical experience. All M. odoratimimus isolates reported in the present paper were extensive drug resistance strains, sensitive only to minocycline and resistant to all the other tested antimicrobials. Two of our patients were successfully treated with tigecycline. Previous studies reported quinolones combined with rifampicin as optimal therapeutic regimens for treating M. odoratimimus UTI. 19 Other sites of Myroides spp. infections benefited from treatment with cotrimoxazole, meropenem, or piperacillin/tazobactam, 12, 14, 17 with favorable clinical responses.
One limitation of the present study could be the lack of pulsed-field gel electrophoresis tests to confirm the outbreak and trace the source of genetically related strains.
Conclusion
Although Myroides spp. are uncommon pathogens, clinicians should be aware of the ability of M. odoratimimus to cause prolonged UTI outbreaks, especially in the immunocompromised population. It is important to identify Myroides spp. infections rapidly in order to choose the best therapeutic regimen, considering the wide range of antibiotic resistance of these microorganisms.
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